Simplify Logo

Full-Time

Scientist II/Senior Scientist I

Nucleic Acid Detection

Confirmed live in the last 24 hours

Mammoth Biosciences

Mammoth Biosciences

51-200 employees

Develops CRISPR-based diagnostic tests for healthcare

Biotechnology
Healthcare

Compensation Overview

$135k - $155kAnnually

Mid, Senior

Daly City, CA, USA

Onsite position in Brisbane, CA.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Molecular Biology, Cell Biology, Biochemistry, Bioengineering, or related fields with 3+ years of relevant professional experience in industry or academia following completion of PhD. For non-PhD candidates, an MS degree with 6+ years of professional experience is required.
  • At least 3 years of hands-on experience with digital PCR, qRT-PCR, droplet digital PCR, RNA-seq and other nucleic acid based molecular biology techniques
  • 2+ years of hands-on experience in at least two of the following areas as they relate to gene therapy drug development: NAT assay validation and qualification; Design and implementation and novel DNA and RNA quantification methods; Generating robust standardized protocols and SOPs as release assays
  • Prior experience with CRO management
  • Prior experience filing INDs for gene therapies
Responsibilities
  • Contribute creatively to the design and development of novel assays for characterizing therapeutic nucleic acids for CRISPR-based therapies
  • Develop scalable and rigorous assays for measuring gene expression, RNA stability and degradation, pharmacokinetics, and therapeutic efficacy
  • Liaise with CROs to qualify and validate assays developed by the team
  • Routinely develop standardized protocols for assays
  • Plan, design, execute and designate assays for CRISPR therapeutic development
  • Provide consultation to other program teams on dPCR, ddPCR, qPCR, RNA-seq and other relevant assays routinely used in early research and later stage drug development
  • Train and provide instructions to junior members of assay development and associated teams on assays
  • Document experiments in electronic lab notebooks and present present data when needed
  • Provide support to automation team scientists to onboard protein detection protocols to high throughput systems
  • Lead team and routinely develop and improve processes to better team functionality

Mammoth Biosciences focuses on molecular diagnostics by using CRISPR technology to develop rapid diagnostic tests that can identify ailments, including infectious diseases like COVID-19, at the point of care. This allows for immediate results, reducing delays associated with traditional lab tests. The company differentiates itself with its versatile CRISPR-based detection platform, which offers a wide range of testing applications. Mammoth's goal is to enhance the accessibility and efficiency of diagnostic testing in response to global health challenges.

Company Stage

Series D

Total Funding

$264.5M

Headquarters

Brisbane, California

Founded

2017

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

-9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Mammoth's collaboration with Regeneron, including a $95M equity investment, underscores strong financial backing and potential for significant revenue through milestone payments and royalties.
  • The company's innovative ultracompact CRISPR systems show promise in developing one-time curative therapies, potentially revolutionizing treatment for genetic diseases.
  • Presentations at prestigious conferences like the American Society of Gene & Cell Therapy highlight Mammoth's leadership and influence in the scientific community.

What critics are saying

  • The recent layoffs indicate potential financial or strategic challenges, which could impact employee morale and job security.
  • The competitive landscape in CRISPR and gene-editing technologies is intense, requiring continuous innovation to maintain a leading position.

What makes Mammoth Biosciences unique

  • Mammoth Biosciences leverages proprietary ultracompact CRISPR technology, setting it apart from competitors in the molecular diagnostics and gene-editing space.
  • Their focus on rapid, point-of-need diagnostic tests provides immediate results, unlike traditional lab-based tests that require longer processing times.
  • Strategic partnerships with industry leaders like Regeneron enhance their capabilities and market reach, distinguishing them from other biotech firms.

Benefits

Medical, dental, & vision

401(k)

Unlimited vacation

Transportation subsidy

Onsite amenities

Happy hours